Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-26-006576

CVP, TAVR sold 619 shares at $91.70 ($56,762)

  • CVP, TAVR acquired 619 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lippis Daniel J. CVP, TAVR 2026-07-10 Option exercise 10b5-1 +619 $72.68 $44,989 40,652.91 D: show line 1 in the form
Lippis Daniel J. CVP, TAVR 2026-07-10 Sale 10b5-1 −619 $91.70 $56,762 40,033.91 D: show line 2 in the form
Open-market sales · 619 sh · avg $91.70 · $56,762

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Lippis Daniel J. CVP, TAVR 2026-07-10 Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 −619 4,952 D: show line 3 in the form
Loading xslF345X06/doc4.xml…